Table 2.

Patient demographics and baseline characteristics (n = 24)

Characteristics
Median (range) age, y63 (44-78)
Gender, n (%)
    Female7 (29)
    Male17 (71)
Baseline labs; median (range)
    Albumin (g/dL)3.3 (2.2-4.5)
    Creatinine (mg/dL)1.0 (0.7-2.4)
    β2-Microglobulin (ng/L)2.56 (0.06-8.28)
    M protein (mg/24 h)1.82 (0-6.85)
    LDH (units/L)130 (83-543)
    Hemoglobin (g/dL)11.9 (7.9-15.7)
Median (range) no. prior therapies3 (1-8)
Prior therapies, n (%)
    Bortezomib13 (54)
    Melphalan12 (50)
    Thalidomide12 (50)
    Lenalidomide6 (25)
    Arsenic trioxide4 (17)
Median duration of disease (range), mo29 (7-114)